Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

US science advisers outline path to genetically modified babies

This article has been updated

Modified human embryos should be allowed if researchers meet strict criteria, says long-awaited National Academies report.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 14 February 2017

    This story has been updated with comments from David Prentice of the Charlotte Lozier Institute in Washington DC.

References

  1. Pan, Y. et al. Sci. Rep. 5, 8296 (2015).

    Article  CAS  Google Scholar 

  2. Mascheretti, S. et al. Psychiat. Genet. 25, 9–20 (2015).

    Article  CAS  Google Scholar 

Download references

Authors

Related links

Related links

Related links in Nature Research

Should you edit your children’s genes? 2016-Feb-23

Gene-editing summit supports some research in human embryos 2015-Dec-03

Human-genome editing summit to sample global attitudes 2015-Nov-30

Genome editing: 7 facts about a revolutionary technology 2015-Nov-30

Related external links

National Academies Consensus Study: Human Genome Editing: Science, Ethics, and Governance

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reardon, S. US science advisers outline path to genetically modified babies. Nature (2017). https://doi.org/10.1038/nature.2017.21474

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2017.21474

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research